Article
31 Oct 2023
PMPRB Adopts Amended Interim Guidelines To Expedite New Patented Medicine Price Reviews
AUTHORS CONTENT
Article
08 Jun 2023
Federal Court Of Appeal Clarifies Test For Inducing Infringement For Generic/Biosimilar Drugs
Article
23 Feb 2023
2022 Year In Review: Life Sciences
Article
07 Dec 2022
A Coming Of Age For The Federal Court Summary Trial In Intellectual Property Litigation
Article
13 Nov 2022
PMPRB Regulations Saga Coming To An End? New Draft Guidelines Issued
Article
03 Jun 2022
Federal Court Sets Aside Minister Of Health's Approval Of RUZURGI For The Second Time Over Data Protection Dispute
Article
25 Apr 2022
Canada Drops Its Most Controversial Patented Drug Pricing Amendments
Article
05 Apr 2022
Supreme Court Of Canada Takes A Pass On Patented Drug Price Dispute
Article
09 Mar 2022
Federal Court Interprets Patent Act Amendments To Prior User Rights Provisions
Article
02 Mar 2022
2021 Year In Review: IP Litigation
Article
01 Mar 2022
Proposed Canadian Drug Pricing Rules Delayed By Feds And Battered By Courts
Article
09 Feb 2022
Soundly Predicted, But Not Obvious: Validity Of MS Drug Patent Upheld On Appeal
Article
24 Nov 2021
Federal Court Finds Minister Of Health's Refusal Of BELSOMRA CSP Unreasonable, Remits For Redetermination
Article
06 Aug 2021
Canadian Drug Price Review Board Reined In
Article
08 Oct 2019
Canadian Drug Price Review Of Generic Companies Holding Patents
Article
09 Aug 2019
While Americans Laud "Low" Canadian Drug Prices, Canadian Innovative Pharma Waits To See If The Pricing Axe Will Fall On "Excessive" Canadian Drug Prices
